一种基于诱导多能干细胞的化学遗传方法,用于研究脊髓肌肉缩
Richard M Giadone1,2,3, Kristina M Holton1,2,3,4, Xiaoyu Hu1,2
1Department of Stem Cell and Regenerative Biology, Harvard University, Cambridge, MA 02138, USA.
bioRxiv : the preprint server for biology
|November 24, 2025
概括
研究人员调整了一个化学遗传平台来研究脊柱肌肉缩 (SMA). 这种方法分析了SMA患者衍生的神经元中的基因表达,有助于发现神经系统疾病的药物.
科学领域:
- 神经科学是一个神经科学.
- 遗传学 遗传学 是一个
- 药物发现 药物发现 药物发现
背景情况:
- 脊髓肌肉缩 (SMA) 是一种影响运动神经元的遗传神经肌肉疾病.
- 目前的SMA疗法需要早期干预,并受到患者遗传学的影响.
- 中枢神经系统 (CNS) 药物发现面临的挑战是由于遗传异质性和早期治疗的需要.
研究的目的:
- 通过化学遗传学方法调整连接地图 (CMAP) / L1000平台,以研究SMA.
- 从SMA患者衍生的神经元生成可查询的转录资料数据集.
- 促进识别可调节SMA和其他中枢神经系统疾病相关基因表达的化合物.
主要方法:
- 从中度和重度的SMA患者中分化的患者特异性诱导多能干细胞 (iPSC) 进入神经细胞.
- 使用前向编程差异化协议.
- 暴露神经元细胞360神经活性或中枢神经系统疾病相关化合物,并使用CMAPneuro平台分析了400多个神经基因的变化,生成4,559个转录资料.
主要成果:
- 从SMA患者衍生的神经元生成了一个包含4,559个转录资料的综合数据集.
- 确定了特定的化合物 (perturbagens),可以调节SMA神经元中的基因表达模式.
- 该CMAPneuro平台为研究界提供了一个可查询的资源.
结论:
- 开发的CMAPneuro平台有效地捕获SMA神经元中的转录反应.
- 该资源使研究人员能够识别模仿或逆转SMA相关基因表达变化的化合物.
- 通过利用患者特定的细胞模型,为SMA和其他复杂的中枢神经系统疾病提供更广泛的药物发现努力.
更多相关视频
07:32Analyzing Mitochondrial Transport and Morphology in Human Induced Pluripotent Stem Cell-Derived Neurons in Hereditary Spastic Paraplegia
Published on: February 9, 2020
8.2K
09:11Generation of Induced Pluripotent Stem Cells from Muscular Dystrophy Patients: Efficient Integration-free Reprogramming of Urine Derived Cells
Published on: January 28, 2015
11.7K
相关概念视频
Induced Pluripotent Stem Cells
5.4K
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
Somatic...
5.4K
Induced Pluripotent Stem Cells
27.2K
Stem cells are undifferentiated cells that divide and produce different types of cells. Ordinarily, cells that have differentiated into a specific cell type are post-mitotic—that is, they no longer divide. However, scientists have found a way to reprogram these mature cells so that they “de-differentiate” and return to an unspecialized, proliferative state. These cells are also pluripotent like embryonic stem cells—able to produce all cell types—and are therefore...
27.2K
Satellite Stem Cells and Muscular Dystrophy
2.3K
Satellite stem cells or myosatellite cells are quiescent stem cells that Alexander Mauro first identified in 1961. These cells are located between the sarcolemma, the plasma membrane of muscle fibers, and the basal lamina, the connective tissue sheath covering it. These mononucleated cells are activated in response to muscle injury, can transform into myoblasts, and may form or repair muscle fibers. Myosatellite cells can provide additional myonuclei for muscle regeneration or return to a...
2.3K
EPS and iPS Cells in Disease Research
3.3K
Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...
3.3K
